Forecast & Rating4 analysts currently cover Vivos Therapeutics, of which 2 give a positive rating. The average price target is $2.12, about 1197.0% upside from the current price of $0.16. Coverage is limited, so the data is for reference only. Data as of Aug 19, 2026; this does not constitute investment advice.
Aug 19, 2026Price forecast
$2.121196.98%
Forecast & RatingBuy
3analysts
- Strong buy66.67%
- Buy0.00%
- Hold33.33%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 14, 2026
Forecast met43.0%
Stock price$0.16
Avg. target$5.5
High target$7
Low target$4
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.